The search for a domestic supply of the radioisotope technetium-99m (tech-99) may have to begin anew as General Electric has temporarily put the brakes on a project at an Illinois nuclear power plant that would have produced molybdenum-99 (Mo-99), which decays into tech-99.
Shine Medical Technologies, a developer of medical isotopes and cancer treatment elements, intends to build a new manufacturing plant in Janesville, Wis. Plant completion is planned for 2015, with more than 100 permanent employees and potential for further employment growth.
The FDA has granted clearances for GE Healthcare's Brivo NM615, a single-head nuclear medicine gamma camera with SPECT capability.
In the wake of the passage of the Deficit Reduction Act (DRA), there were concerns that advanced imaging procedures would shift from private offices to hospital outpatient departments and that access would be restricted. According to a study in the January issue of the Journal of the American College of Radiology, while there hasn’t been a large shift away from offices toward hospitals, the DRA did affect imaging volume and seems to have resulted in some loss of access to nuclear medicine.
Following a two-day public hearing, the Canadian Nuclear Safety Commission announced its decision Oct. 27 to renew the Atomic Energy of Canada Limited's (AECL) Chalk River Laboratories operating license for a period of five years. The license will be valid from Nov. 1 until Oct. 31, 2016.
Citing significant variations in pediatric radiopharmaceutical doses and package inserts lacking pediatric doses, the authors of an article appearing in the November issue of Radiology indicated recently approved consensus guidelines for pediatric administered radiopharmaceutical doses may help solve the problem.
Patients seeking information about nuclear medicine and molecular imaging can now access discoverMI.org, a patient-focused website launched by the Society of Nuclear Medicine (SNM).
Total nuclear medicine procedures have been relatively flat, and trending slightly downward, from 2007 to 2010, according to a report from IMV Medical Information Division.
Areva's nuclear medicine subsidiary, Areva Med, has acquired Macrocyclics for an undisclosed sum.
The Society of Nuclear Medicine Technologist Section has re-launched its Professional Development and Education Fund, which was created in 2001, and aims to support the advancement of molecular and nuclear medicine technologists through professional development that promotes clinical excellence and optimal patient outcomes.
The Society of Nuclear Medicine has announced the theme for this year’s Nuclear Medicine Week, Oct. 2-8, is “Visualizing a Brighter and Healthier Tomorrow,” and released a toolkit for nuclear and molecular imaging professionals.
The National Science Foundation (NSF) has issued a $5 million, three-year grant to fund ongoing research titled "Studies of Nuclear Reactions and Structure" at Florida State University. The project was previously awarded $4.4 million by the NSF in 2008.
Centric Health has entered into an agreement to acquire Medical Imaging Centres and certain business assets of Rads 24/7 Teleradiology Consultants for up to $36.2 million.
The Society of Nuclear Medicine (SNM) has announced the recipients of the 2011-2013 SNM Wagner-Torizuka Fellowship, which is a two-year fellowship designed to provide extensive training and experience in the fields of nuclear medicine and molecular imaging for Japanese physicians in the early stages of their careers.
International Isotopes (INIS), a manufacturer of nuclear medicine products, has completed the process for the receipt of property transferred from the State of New Mexico and Lea County to the company, which plans to use the remaining property as a buffer zone for future expansion and for the potential co-location of prospective customer facilities utilizing the fluoride products produced from de-conversion and fluorine extraction.
SAN ANTONIO—According to the Centers for Medicare & Medicaid Services (CMS), all non-hospital providers of advanced diagnostic imaging, inclusive of nuclear medicine, MR, CT and PET, must obtain accreditation as a condition for reimbursement by Jan. 1, 2012. Just who is authorized to offer such accreditation was the subject of a June 26 afternoon presentation at the 2011 Association for the Advancement of Medical Instrumentation (AAMI) conference & expo.
Candu Energy, a wholly owned subsidiary of SNC-Lavalin Group, has agreed with the Government of Canada to acquire certain assets of Atomic Energy of Canada’s (AECL) commercial reactor division for a purchase price of CAD15 million (USD $15.59 million) and royalty payments from future new build and life extension projects. AECL will retain its past liabilities.
Myocardial perfusion reserve (MPR) is a more sensitive predictor for cardiac death than left ventricular ejection fraction and extent of viability, based on a study in this month’s Journal of Nuclear Medicine.
Known to be significantly more susceptible to dementia, individuals with Down syndrome appear to display age-related increases in amyloid senile plaques and tau neurofibrillary tangles that mirror those increases in Alzheimer’s patients as viewed with PET, according to a study published in the June issue of Archives of Neurology.
The FDA sent Philips Healthcare of North Andover, Mass, a warning letter on June 7, noting that manufacturing methods at its Cleveland facilities do not conform with required current good manufacturing processes.
|
RSS 
